MyFinsight
Home
About
Contact
Back
Income Statement
Entero Therapeutics, Inc. (ENTO)
source: myfinsight.com
Download
Download image
Net loss applicable
to common...
-$1,080,436
Net loss
-$998,271
Preferred stock dividends
$82,165
Net loss from
continued operations
-$674,931
Loss from
discontinued operations net...
-$323,340
Loss from continued
operations
-$674,931
Total other expenses
-$36,067
Loss from operations
-$638,864
Interest income
(expense), net
-$36,067
Total operating
expenses
$638,864
General and
administrative expenses
$628,233
Research and development
expenses
$10,631
Back